Literature DB >> 29319622

A High Portal Venous Pressure Gradient Increases Gut-Related Bacteremia and Consequent Early Mortality After Living Donor Liver Transplantation.

Siyuan Yao1, Shintaro Yagi1, Ryuji Uozumi2, Taku Iida3, Miki Nagao4, Yusuke Okamura1, Takayuki Anazawa1, Hideaki Okajima1, Toshimi Kaido1, Shinji Uemoto1.   

Abstract

BACKGROUND: Portal hypertension (PHT) is defined as a portal venous pressure gradient (PVPG) exceeding 5 mm Hg, which results in severe clinical manifestations. However, the validity of intraoperative PVPG monitoring and the association between PHT and bacterial translocation after liver transplantation remain unclear.
METHODS: In this retrospective study, 223 patients who underwent primary adult-to-adult living donor liver transplantation from 2008 to 2015 were divided into 2 groups based on the PVPG at the end of the operation: high PVPG (>5 mm Hg, n = 69) and low PVPG (≤5 mm Hg, n = 154). The clinical factors were compared between the groups, and the association between a high PVPG and posttransplant bacteremia/bacterial infections was investigated.
RESULTS: The high PVPG group had a significantly higher incidence of bacteremia (46% vs 24%, P < 0.001), higher 90-day mortality rate (20% vs 7%, P = 0.002), and poorer 1-year survival (71% vs 86%, P = 0.006). The high PVPG group had a particularly higher incidence of bacteremia caused by "gut bacteria" including Enterobacteriaceae, Bacteroides spp., and Enterococcus spp. (29% vs 12%, P = 0.003). Multivariate analysis showed that a PVPG greater than 5 mm Hg (odds ratio, 2.55; 95% confidence interval, 1.18-5.55; P = 0.017) was an independent predictor of bacteremia due to gut bacteria.
CONCLUSIONS: Monitoring of the PVPG is clinically meaningful for predicting patients' prognosis. In particular, a high PVPG with a threshold of 5 mm Hg at the end of adult-to-adult living donor liver transplantation may increase gut-related bacteremia through the mechanism of bacterial translocation, resulting in early mortality.

Entities:  

Mesh:

Year:  2018        PMID: 29319622     DOI: 10.1097/TP.0000000000002047

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation.

Authors:  Siyuan Yao; Shintaro Yagi; Miki Nagao; Ryuji Uozumi; Taku Iida; Sena Iwamura; Yosuke Miyachi; Hisaya Shirai; Atsushi Kobayashi; Shinya Okumura; Yuhei Hamaguchi; Yuuki Masano; Toshimi Kaido; Hideaki Okajima; Shinji Uemoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-23       Impact factor: 3.267

2.  Single Orifice Outflow Reconstruction: Refining the Venous Outflow in Modified Right Lobe Live Donor Liver Transplantation.

Authors:  Viniyendra Pamecha; Bramhadatta Pattnaik; Piyush Kumar Sinha; Nilesh Sadashiv Patil; Nihar Mohapatra; Shridhar Vasantrao Sasturkar; Venkatesh Balaraman Sundararajan; Shalini Thapar; Gaurav Sindwani; Mahesh Kumar Arora
Journal:  J Gastrointest Surg       Date:  2020-08-17       Impact factor: 3.452

3.  Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.

Authors:  Jian-Zhong Ye; Ya-Ting Li; Wen-Rui Wu; Ding Shi; Dai-Qiong Fang; Li-Ya Yang; Xiao-Yuan Bian; Jing-Jing Wu; Qing Wang; Xian-Wan Jiang; Cong-Gao Peng; Wan-Chun Ye; Peng-Cheng Xia; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

4.  Pulse oximetry-based capillary refilling evaluation predicts postoperative outcomes in liver transplantation: a prospective observational cohort study.

Authors:  Miyuki Yamamoto; Kent Doi; Naoki Hayase; Toshifumi Asada; Nobuhisa Akamatsu; Junichi Kaneko; Kiyoshi Hasegawa; Naoto Morimura
Journal:  BMC Anesthesiol       Date:  2020-09-29       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.